Health officials investigating whether vaccine causes blood clots
Health Canada is keeping tabs on European investigations into the Oxford-AstraZeneca vaccine after overseas reports of some recipients developing blood clots following inoculations.
For now, the government agency is assuring Canadians that the ''benefits of the vaccine continue to outweigh its risks.''
It says it authorized the vaccine for Canadian use based on a thorough review.
At least nine European countries as well as, Thailand, have temporarily suspended their use of AstraZeneca's doses pending investigation of blood clots, though none suggest there is a link between the two.
Habitat for Humanity Building in Thorold
Police Target Trucks By-Passing Inspection
Bob Cole Dies at the Age of 90
Suspect Sought After Cannabis Store Robbery
Niagara Transit to Receive Gas Tax Money
Local Power Company Upgrading Technology
Police Called Concerning Armed Individual
Man Arrested in Connection to School Threats